BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24169360)

  • 1. External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours.
    Bendifallah S; Uzan C; Fauvet R; Morice P; Darai E
    Br J Cancer; 2013 Nov; 109(11):2774-7. PubMed ID: 24169360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on 'External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours'.
    Obermair A
    Br J Cancer; 2014 Dec; 111(12):2375. PubMed ID: 24448362
    [No Abstract]   [Full Text] [Related]  

  • 3. [External multicentric validation of two scores predicting the risk of relapse in patients with borderline ovarian tumors: The nomogram of Bendifallah and the score of Ouldamer].
    Pais P; Huchon C; Chevrot A; Cohen J; Fauconnier A; Rouzier R; Mimouni M
    Bull Cancer; 2017 Sep; 104(9):721-726. PubMed ID: 28778341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to 'Comment on external multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours'.
    Bendifallah S; Darai E
    Br J Cancer; 2014 Dec; 111(12):2375-6. PubMed ID: 24755881
    [No Abstract]   [Full Text] [Related]  

  • 5. Nomogram to predict the probability of relapse in patients diagnosed with borderline ovarian tumors.
    Obermair A; Tang A; Kondalsamy-Chennakesavan S; Ngan H; Zusterzeel P; Quinn M; Carter J; Leung Y; Janda M
    Int J Gynecol Cancer; 2013 Feb; 23(2):264-7. PubMed ID: 23295940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours.
    Ouldamer L; Bendifallah S; Naoura I; Body G; Uzan C; Morice P; Ballester M; Daraï E
    Hum Reprod; 2016 Aug; 31(8):1732-7. PubMed ID: 27496944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer.
    Polterauer S; Zhou Q; Grimm C; Seebacher V; Reinthaller A; Hofstetter G; Concin N; Leitao MM; Barakat RR; Abu-Rustum NR; Iasonos A
    Gynecol Oncol; 2012 Jun; 125(3):526-30. PubMed ID: 22449735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic and extrinsic flaws of the nomogram predicting bone-only metastasis in women with early breast cancer: An external validation study.
    Ouldamer L; Bendifallah S; Chas M; Boivin L; Bedouet L; Body G; Ballester M; Daraï E
    Eur J Cancer; 2016 Dec; 69():102-109. PubMed ID: 27821312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram to predict recurrence in patients with early- and advanced-stage mucinous and serous borderline ovarian tumors.
    Bendifallah S; Ballester M; Uzan C; Fauvet R; Morice P; Darai E
    Am J Obstet Gynecol; 2014 Dec; 211(6):637.e1-6. PubMed ID: 24949545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma.
    Hu J; Jiao X; Zhu L; Guo H; Wu Y
    BMC Cancer; 2020 Sep; 20(1):938. PubMed ID: 32993522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
    Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
    Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for progression to invasive carcinoma in patients with borderline ovarian tumors.
    Song T; Lee YY; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
    Int J Gynecol Cancer; 2014 Sep; 24(7):1206-14. PubMed ID: 25078337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients.
    Shim SH; Lee SJ; Kim SO; Kim SN; Kim DY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2015 Jan; 136(1):30-6. PubMed ID: 25448457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.
    Ganly I; Amit M; Kou L; Palmer FL; Migliacci J; Katabi N; Yu C; Kattan MW; Binenbaum Y; Sharma K; Naomi R; Abib A; Miles B; Yang X; Lei D; Bjoerndal K; Godballe C; Mücke T; Wolff KD; Fliss D; Eckardt AM; Chiara C; Sesenna E; Ali S; Czerwonka L; Goldstein DP; Gil Z; Patel SG
    Eur J Cancer; 2015 Dec; 51(18):2768-76. PubMed ID: 26602017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer.
    Kim JH; Kim HS; Seo WY; Nam CM; Kim KY; Jeung HC; Lai JF; Chung HC; Noh SH; Rha SY
    Ann Oncol; 2012 Feb; 23(2):361-7. PubMed ID: 21566150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
    Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a nomogram for predicting outcome of patients with vulvar cancer.
    Rouzier R; Preti M; Haddad B; Martin M; Micheletti L; Paniel BJ
    Obstet Gynecol; 2006 Mar; 107(3):672-7. PubMed ID: 16507940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery].
    Margueritte F; Sallee C; Lacorre A; Gauroy E; Larouzee E; Chereau E; De La Motte Rouge T; Koskas M; Gauthier T
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):248-259. PubMed ID: 32004784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
    Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
    Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
    Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
    Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.